Study yields potential drug targets for preeclampsia patients

April 29, 2014

Preeclampsia, the most common complication of pregnancy, is a major cause of premature delivery and both maternal and fetal death, yet what causes the syndrome remains unclear. A new study indicates that molecules that send detrimental signals are abundant in certain tissues in preeclampsia patients. The study also documented some of the complications experienced by babies born to mothers with preeclampsia.

"Preeclampsia is a multifaceted complication found uniquely in the and one that has puzzled scientists for years," says the leader of the study, Mohammad N. Uddin, a research scientist and assistant professor in the obstetrics and gynecology department of the Scott & White Healthcare/Texas A&M Health Science Center College of Medicine in Temple, Texas.

Preeclampsia affects about 5 percent of expectant moms, usually in the second half of pregnancy. "By conservative estimates, these disorders are responsible for 76,000 maternal and 500,000 infant deaths each year" around the world, according to the Preeclampsia Foundation. Preeclampsia's hallmarks are high blood pressure and an overload of protein in the urine. Treatment options are limited, but the syndrome eventually goes away after birth.

During pregnancy, the placenta functions like a trading post of sorts: Inside the pancake-shaped organ, maternal and fetal blood is trucked through, nutrients and oxygen are delivered to the developing fetus, and waste products are shipped out for disposal. All of that life-sustaining traffic requires a multitude of molecular signals, and Uddin's study zeroed in on the bad signals that may be involved in .

Uddin's team compared protein expression in samples from placentas and umbilical cords of 10 women who had experienced preeclampsia and 10 who had not. (The researchers also conducted the same analysis with rats.) They found that proteins that signal both cell stress and were significantly higher in samples taken from the women who had experienced preeclampsia, Uddin says.

"Stress and (programmed cell death) signaling was upregulated in preeclamptic placentas and umbilical cords compared with normal pregnancies," Uddin says. In fact, the ratio of molecules Bax/Bcl-2, which is involved in programmed cell death, was increased 1.4-fold. Meanwhile the molecule Cox-2, which is related to inflammation, and the enzyme p38 MAPK, which is related to cell stress, were increased 2.5-fold and 3.0-fold, respectively.

The researchers say that the increase in those factors could reduce nutrient transport and send bad signals to the maternal vascular system, which circulates blood. In addition, Uddin says, these circulating factors may pass the placental barrier: "The fetus has to adapt to this impending intrauterine environment and detrimental signaling, and this adaptation increases the risk of disease happening later in life."

In addition to analyzing what molecules were more pronounced in preeclampsia, the researchers were interested in learning more about the effects of the syndrome on study participants' babies. They found that the average hospital stay for preeclampsia babies was significantly longer: Those newborns stayed six days on average, while the babies born to mothers without preeclampsia stayed a little over three days on average.

While there were no complications reported for the babies from normal pregnancies, the babies with preeclamptic moms had a slew of issues: One had low blood sugar; four had jaundice; three had respiratory distress syndrome; one had extra and fused digits; one was overdue; one had abnormal abdominal fluid accumulation; and one had intrauterine growth restriction.

Uddin noted that there are numerous well-known effects of preeclampsia on babies: "These long-term effects are increased risks of hypertension and type 2 diabetes mellitus, aortic wall thickening (an early marker of atherosclerosis in children), increased risk of stroke, intellectual disabilities, hearing disabilities, neurodevelopmental delay, cerebral palsy and an increased risk of metabolic disorders."

Uddin says that the team's identification of the molecules overexpressed in the tissues from preeclampsia patients raises the possibility that those signals could be therapeutically blocked one day.

Explore further: Biomarkers provide potential for better preeclampsia detection

More information: Mohammad N. Uddin presented the team's findings during the Experimental Biology 2014 meeting on Monday, April 28, at the Cell Signaling poster session in Exhibit Halls A-D (Poster #D324), San Diego Convention Center.

Related Stories

Biomarkers provide potential for better preeclampsia detection

March 17, 2014
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) ...

Pregnancy complications may be more common in immigrants from certain regions

April 24, 2014
Pregnant immigrants from Sub-Saharan Africa, Latin America and Caribbean islands may require increased monitoring during pregnancy, according to new research from St. Michael's Hospital.

Preeclampsia poses a significant long-term health risk: study

September 4, 2012
Ben-Gurion University of the Negev (BGU) researchers have determined that preeclampsia is a significant risk factor for long-term health issues, such as chronic hypertension and hospitalizations later in life. The findings ...

Aspirin advised for women at high risk for pregnancy complication (Update)

April 8, 2014
(HealthDay)—Pregnant women at high risk for the serious condition called preeclampsia should take low-dose aspirin every day after their first trimester, according to a new draft recommendation by an influential U.S. panel ...

Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

February 11, 2012
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in ...

Low vitamin D levels during pregnancy may increase risk of severe preeclampsia

January 27, 2014
(Medical Xpress)—Women who are deficient in vitamin D in the first 26 weeks of their pregnancy may be at risk of developing severe preeclampsia, a potentially life-threatening disorder diagnosed by an increase in blood ...

Recommended for you

Sleeping position linked to the risk of stillbirth

November 20, 2017
Pregnant women who go to sleep on their back during the later stages of pregnancy face an increased likelihood of suffering a stillbirth, according to new research.

Study in mice finds dietary levels of genistein may adversely affect female fertility

November 14, 2017
Exposure to the phytoestrogen genistein prior to conception may adversely affect female fertility and pregnancy outcomes, depending on the dosage and duration of exposure, a new study in mice suggests.

IUDs may have a surprising benefit: Protection against cervical cancer

November 7, 2017
Considered a safe and highly effective contraception method, intrauterine devices (IUDs) may also be quietly offering protection against the third-most common cancer in women worldwide. A new study from the Keck School of ...

Increasing rates of chronic conditions putting more moms, babies at risk

November 7, 2017
Pregnant women today are more likely to have chronic conditions that could cause life-threatening complications than at any other time in the past decade - particularly poor women and those living in rural communities, a ...

First time mums with an epidural who lie down more likely to have a normal birth

October 18, 2017
Adopting a lying down position rather than being upright in the later stages of labour for first-time mothers who have had a low dose epidural leads to a higher chance of them delivering their baby without any medical intervention, ...

Mice delivered by C-section gain more weight than those delivered naturally

October 11, 2017
Mice born by Caesarian section gained on average 33 percent more weight in the 15 weeks after weaning than mice born vaginally, with females gaining 70 percent more weight.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.